This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Infliximab Top-down in Pediatric Crohn (ITSKids)
Clinical trial

Infliximab Top-down in Pediatric Crohn (ITSKids)

Read time: 1 mins
Last updated:7th Jun 2013
The purpose of this study is to determine whether a top-down treatment approach, prescribing infliximab and azathioprine at diagnose, yields better outcome in comparison to the usual step-up treatment approach, starting with prednison and azathioprine, in moderate-to-severe pediatric Crohn's disease (CD) patients.
Category Value
Study start date 2013-06-07

View full details